Mass Spectrometry Imaging Spatial Tissue Analysis toward Personalized Medicine

15Citations
Citations of this article
25Readers
Mendeley users who have this article in their library.

Abstract

Novel profiling methodologies are redefining the diagnostic capabilities and therapeutic approaches towards more precise and personalized healthcare. Complementary information can be obtained from different omic approaches in combination with the traditional macro- and microscopic analysis of the tissue, providing a more complete assessment of the disease. Mass spectrometry imaging, as a tissue typing approach, provides information on the molecular level directly measured from the tissue. Lipids, metabolites, glycans, and proteins can be used for better understanding imbalances in the DNA to RNA to protein translation, which leads to aberrant cellular behavior. Several studies have explored the capabilities of this technology to be applied to tumor subtyping, patient prognosis, and tissue profiling for intraoperative tissue evaluation. In the future, intercenter studies may provide the needed confirmation on the reproducibility, robustness, and applicability of the developed classification models for tissue characterization to assist in disease management.

Cite

CITATION STYLE

APA

Gonçalves, J. P. L., Bollwein, C., & Schwamborn, K. (2022, July 1). Mass Spectrometry Imaging Spatial Tissue Analysis toward Personalized Medicine. Life. MDPI. https://doi.org/10.3390/life12071037

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free